Log In
Print
BCIQ
Print
Print this Print this
 

Cenicriviroc (formerly TBR-652)

Also known as: formerly TAK-652

  Manage Alerts
Collapse Summary General Information
Company Takeda Pharmaceutical Co. Ltd.
DescriptionDual CC chemokine receptor 5 (CCR5; CD195) and CCR2 (CD192) antagonist
Molecular Target CC chemokine receptor 5 (CCR5) (CD195) ; CC chemokine receptor 2 (CCR2) (CD192)
Mechanism of ActionCC chemokine receptor 2 (CCR2) antagonist; CC chemokine receptor 5 (CCR5) antagonist
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today